Purpose/Objectives: To review the literature regarding the incidence, current practice, guideline recommendations, nursing management, and knowledge gaps relevant to vesicant extravasation.
condensed the minimum standards for practice and is useful in any setting where chemotherapy is administered. However, management of extravasation remains largely based on anecdotes of "effi cacious" interventions in small samples or in single clinical cases (Kretzschmar et al., 2003) . Consequently, oncology nurses, physicians, and pharmacists face the challenge of determining best practice with a less-than-ideal body of evidence to support clinical decision making. Practitioner awareness and patient management that include use of current guidelines, as well as systematic data collection and case reporting, can contribute to the further development of evidence-based patient care. 
Vesicant Extravasation

Spectrum of Extravasation
Extravasation is the inadvertent leakage or escape of a drug or solution from a vein or unintentional injection into surrounding healthy tissues. Occurrences of vesicant chemotherapy extravasation may be underreported but are estimated to occur in 0.1%-6% of peripheral IV infusions This material is protected by U.S. copyright law. Unauthorized reproduction is prohibited. To purchase quantity reprints, please e-mail reprints@ons.org or to request permission to reproduce multiple copies, please e-mail pubpermissions@ons.org.
